全文获取类型
收费全文 | 125934篇 |
免费 | 9784篇 |
国内免费 | 3575篇 |
专业分类
耳鼻咽喉 | 993篇 |
儿科学 | 2340篇 |
妇产科学 | 1799篇 |
基础医学 | 7010篇 |
口腔科学 | 2877篇 |
临床医学 | 15088篇 |
内科学 | 18706篇 |
皮肤病学 | 2309篇 |
神经病学 | 6429篇 |
特种医学 | 4030篇 |
外国民族医学 | 39篇 |
外科学 | 12322篇 |
综合类 | 18582篇 |
现状与发展 | 23篇 |
一般理论 | 2篇 |
预防医学 | 5329篇 |
眼科学 | 2040篇 |
药学 | 10367篇 |
75篇 | |
中国医学 | 11372篇 |
肿瘤学 | 17561篇 |
出版年
2024年 | 219篇 |
2023年 | 2166篇 |
2022年 | 3525篇 |
2021年 | 5544篇 |
2020年 | 5182篇 |
2019年 | 4653篇 |
2018年 | 4411篇 |
2017年 | 4895篇 |
2016年 | 5203篇 |
2015年 | 4977篇 |
2014年 | 9032篇 |
2013年 | 11479篇 |
2012年 | 7452篇 |
2011年 | 7935篇 |
2010年 | 6559篇 |
2009年 | 6030篇 |
2008年 | 5884篇 |
2007年 | 6324篇 |
2006年 | 5656篇 |
2005年 | 5004篇 |
2004年 | 4076篇 |
2003年 | 3679篇 |
2002年 | 3013篇 |
2001年 | 2666篇 |
2000年 | 2209篇 |
1999年 | 1738篇 |
1998年 | 1432篇 |
1997年 | 1208篇 |
1996年 | 1004篇 |
1995年 | 906篇 |
1994年 | 710篇 |
1993年 | 549篇 |
1992年 | 485篇 |
1991年 | 453篇 |
1990年 | 382篇 |
1989年 | 330篇 |
1988年 | 327篇 |
1987年 | 277篇 |
1986年 | 221篇 |
1985年 | 258篇 |
1984年 | 230篇 |
1983年 | 168篇 |
1982年 | 167篇 |
1981年 | 164篇 |
1980年 | 134篇 |
1979年 | 127篇 |
1978年 | 66篇 |
1977年 | 42篇 |
1976年 | 50篇 |
1975年 | 33篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
151.
内镜治疗技术的发展进一步推动了早期胃癌的微创治疗。然而,随之而来的问题是,部分接受内镜治疗的病人会出现非治愈性切除。早期胃癌内镜治疗后非治愈性病人的后续处理原则值得进一步关注。结合欧洲肿瘤内科学会(ESMO)、美国国家综合癌症网络(NCCN)及日本胃癌学会等国际指南及相关临床研究并回顾分析单中心数据后可得出结论,eCura-C的病人具有相对较高的癌残留风险,在与病人充分沟通后可考虑追加手术,但仍有较高的术后病理学无癌残留的风险。术式选择和切除范围可参考早期胃癌相关规定。如何准确预测非治愈性病人的淋巴结转移仍是未来的重点。前哨淋巴结活检及腹腔镜内镜联合手术是未来的发展方向。 相似文献
152.
Luis J García-Flórez Guillermo Gómez-álvarez Ana M Frunza Luis Barneo-Serra Manuel F Fresno-Forcelledo 《World journal of gastrointestinal surgery》2015,7(9):196-202
AIM: To establish the association between lymph node involvement and the response to neoadjuvant therapy in locally advanced rectal cancer.METHODS: Data of 130 patients with mid and low locally advanced rectal adenocarcinoma treated with neoadjuvant chemoradiation followed by radical surgery over a 5-year period were reviewed. Tumor staging was done by endorectal ultrasound and/or magnetic resonance imaging. Tumor response to neoadjuvant therapy was determined by T-downstaging and tumor regression grading (TRG). Pathologic complete response (pCR) is defined as the absence of tumor cells in the surgical specimen (ypT0N0). The varying degrees TRG were classified according to Mandard’s scoring system. The evaluation of the response is based on the comparison between previous clinico-radiological staging and the results of pathological evaluation. χ2 and Spearman’s correlation tests were used for the comparison of variables.RESULTS: Pathologic complete response (pCR, ypT0N0, TRG1) was observed in 19 cases (14.6%), and other 18 (13.8%) had only very few residual malignant cells in the rectal wall (TRG2). T-downstaging was found in 63 (48.5%). Mean lymph node retrieval was 9.4 (range 0-38). In 37 cases (28.5%) more than 12 nodes were identified in the surgical specimen. Preoperative lymph node involvement was seen in 77 patients (59.2%), 71 N1 and 6 N2. Postoperative lymph node involvement was observed in 41 patients (31.5%), 29 N1 and 12 N2, while the remaining 89 were N0 (68.5%). In relation to ypT stage, we found nodal involvement of 9.4% in ypT0-1, 22.2% in ypT2 and 43.7% in ypT3-4. Of the 37 patients considered “responders” to neoadjuvant therapy (TRG1 and 2), there were only 4 N+ (10.8%) and the remainder N0 (89.2%). In the “non responders” group (TRG 3, 4 and 5), 37 cases were N+ (39.8%) and 56 (60.2%) were N0 (P < 0.001).CONCLUSION: Response to neoadjuvant chemoradiation in rectal cancer is associated with lymph node involvement. 相似文献
153.
目前化疗仍为晚期胃癌的标准治疗手段,而多数患者诊断时已接近晚期。近年新兴的免疫治疗手段程序性死亡蛋白-1(PD-1,programmed death l)抗体,通过阻断肿瘤细胞逃避自身免疫机制,重新激活自身免疫对肿瘤的杀伤作用,从而达到肿瘤的治疗作用。针对晚期胃癌的PD-1抗体治疗的临床研究已在国内外开展,大部分均有较好效果。本文对近年免疫治疗中的PD-1抗体在晚期胃癌的重要临床研究进展进行介绍。 相似文献
154.
155.
156.
结直肠癌是常见的消化道肿瘤,其营养不良发生率高且严重。化疗是结直肠癌常见治疗方式之一,并与营养不良独立相关,化疗后患营养不良风险增大且营养不良进一步加重。同时,营养不良可导致患者化疗疗效差及预后不良,并增加化疗相关不良反应、影响患者生活质量及降低生存率等。营养治疗能够有效改善患者营养状况,在肿瘤综合治疗中有重要作用,且多学科团队合作是有效的营养干预模式。目前营养治疗主要包括营养咨询、口服营养补充剂、肠内营养和肠外营养等,相关指南和研究表明在营养治疗时应首选口服营养补充剂及肠内营养,仅在采用以上治疗后仍存在营养不足或无法进行肠内营养时行肠外营养。本文主要对结直肠癌患者营养状况与化疗之间关系、营养治疗的最新研究进展及相关指南进行综述,以期引起临床上对结直肠癌化疗患者营养治疗方面重视并提供参考。 相似文献
157.
ObjectivesThis study aimed to investigate the efficacy of a vacuum myofascial therapy device (VT) for improving pressure pain thresholds (PPTs), range of motion (ROM), neck pain-related disability, pain, and quality of life in patients with non-specific neck pain.MethodsA randomized controlled trial in which thirty-eight participants with non-specific neck pain (NP) were randomly assigned to either an experimental (VT) or a comparison physical therapy program (PTP) group. The VT group (n = 19) received five sessions of treatment with a vacuum myofascial therapy device while the PTP group (n = 19) received five sessions of massage, ultrasound therapy (US), and transcutaneous electric nerve stimulation (TENS) over two weeks. The outcome measures were the numerical pain rating scale (NPRS), range of motion, quality of life (SF-12), neck disability Index (NDI), and PPTs at the end of treatment and at one-month follow-up.ResultsAlthough both groups experienced improvements in pain, neck disability, range of motion, and pressure pain, these only were statistically significant in the VT group. At one-month follow-up, the VT group still showed improvements in pain, neck disability, and range of motion.DiscussionVacuum myofascial therapy applied with a device offers similar results to other vacuum-based techniques such as cupping therapy. Moreover, in this device the parameters are digitally controlled, which allows for the precise reproduction of treatment. 相似文献
158.
The first observations of altered metabolism in malignant cells were made nearly 100 years ago and therapeutic strategies targeting cell metabolism have been in clinical use for several decades. In this review, we summarize our current understanding of cell metabolism dysregulation in childhood acute lymphoblastic leukemia (cALL). Reprogramming of cellular bioenergetic processes can be expected in the three distinct stages of cALL: at diagnosis, during standard chemotherapy, and in cases of relapse. Upregulation of glycolysis, dependency on anaplerotic energy sources, and activation of the electron transport chain have all been observed in cALL. While the current treatment strategies are tackling some of these aberrations, cALL cells are likely to be able to rewire their metabolism in order to escape therapy, which may contribute to a refractory disease and relapse. Finally, here we focus on novel therapeutic approaches emerging from our evolving understanding of the alterations of different metabolic networks in lymphoblasts. 相似文献
159.
160.
Fereydoun DAVATCHI Mahmood AKBARIAN Farhad SHAHRAM Abdolhadi NADJI Farhad GHARIBDOOST Ahmad‐Reza JAMSHIDI 《International journal of rheumatic diseases》2006,9(1):60-63
Aim: To evaluate the overall effect of disease modifying anti‐rheumatic drug (DMARD) combination therapy in daily practice. Methods: In a retrospective study, 161 consecutive files of patients who attended regular follow‐up sessions, seen from 1998, were analysed. Their data were extracted at baseline, 6 months, 1, 2, 3, 4 and 5 years. American College of Rheumatology ACR70 criteria was chosen for the evaluation of the global result. DMARD combination was methotrexate (7.5–15 mg weekly) and chloroquine (150 mg daily), with low‐dose prednisolone (less than 10 mg daily). In cases of remission, methotrexate was gradually tapered, then prednisolone. Chloroquine was discontinued after 1 year if no recurrence occurred at low‐dose (150 mg every other day). In cases of recurrence at any stage, the treatment scheme was stepped back. Results: The data of 161 patients were analysed. One hundred and six were rheumatoid factor positive (RF+) (66%). ACR 70 for all patients at 6 months follow‐up was 72.5% (95% CI = 7.0); at 1 year, 75.8% (95% CI = 6.7); at 2 years, 72.2% (95% CI = 7.2); at 3 years, 78.9% (95% CI = 6.6); at 4 years, 78.4% (95% CI = 6.9); and at 5 years, 70.6% (95% CI = 8.5). Conclusion: The classical DMARD combination therapy, when used with adequate low‐dose prednisolone, gave an ACR70 response from 71–79%. The efficacy of the treatment did not fade over time. RF– patients did better than RF+ patients, but the difference was not statistically significant. 相似文献